Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Direk Limmathurotsakul

Dados Biográficos

ID9065354
NOMEDirek Limmathurotsakul
PRENOMESDirek
SOBRENOMELimmathurotsakul
ASSINATURALIMMATHUROTSAKUL D
AFILIAÇÕESMahidol University
ORCID0000-0001-7240-5320
VERIFICADOSim
TOTAL DE OBRAS5
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2020
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H0
  • Association between Charlson Comorbidity Index and positive blood cultures at a tertiary-care hospital in Indonesia

    Open Access•Patricia M Tauran, Mansyur Arif et al.•ARTICLE•PLOS Global Public Health•2025

    Blood culture (BC) tests are a scarce resource in low- and middle-income countries (LMICs); therefore, prioritization based on likelihood of positive results might be beneficial. We aimed to determine whether comorbidities in the Charlson Comorbidity Index (CCI) were associated with positive BC tests among patients with suspected hospital-acquired bacteremia. We analysed a retrospective cohort from health records at Dr. Wahidin Sudirohusodo Hospi…

  • Use of antimicrobials during the Covid-19 pandemic

    Open Access•Binod Dhungel, Upendra Thapa Shrestha et al.•ARTICLE•PLOS Global Public Health•2023

    The COVID-19 pandemic was a major public health threat and the pressure to find curative therapies was tremendous. Particularly in the early critical phase of the pandemic, a lot of empirical treatments, including antimicrobials, were recommended. Drawing on interviews with patients, clinicians and drug dispensers, this article explores the use of antimicrobials for the management of COVID-19 in Nepal. A total of 30 stakeholders (10 clinicians, 1…

  • Global burden of bacterial antimicrobial resistance in 2019

    Open Access•Christopher J L Murray, Kevin S Ikuta et al.•ARTICLE•The Lancet•2022

    BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) a…

  • Excess mortality attributable to antimicrobial-resistant bacterial bloodstream infection at a tertiary-care hospital in Indonesia

    Open Access•Patricia M Tauran, Irawaty Djaharuddin et al.•ARTICLE•PLOS Global Public Health•2022

    The burden of antimicrobial-resistant (AMR) infections in low and middle-income countries (LMICs) is largely unknown. Here, we evaluate attributable mortality of AMR infections in Indonesia. We used routine databases of the microbiology laboratory and hospital admission at Dr. Wahidin Sudirohusodo Hospital, a tertiary-care hospital in South Sulawesi from 2015 to 2018. Of 77,752 hospitalized patients, 8,341 (10.7%) had at least one blood culture t…

  • Leapfrogging laboratories

    Open Access•Iruka N Okeke, Nicholas Feasey et al.•ARTICLE•BMJ Global Health•2020

    The scope and trajectory of today’s escalating antimicrobial resistance (AMR) crisis is inadequately captured by existing surveillance systems, particularly those of lower income settings. AMR surveillance systems typically collate data from routine culture and susceptibility testing performed in diagnostic bacteriology laboratories to support healthcare. Limited access to high quality culture and susceptibility testing results in the dearth of A…

Sem obras proeminentes nesta página.

  • Leapfrogging laboratories

    Open Access•Iruka N Okeke, Nicholas Feasey et al.•ARTICLE•BMJ Global Health•2020

    The scope and trajectory of today’s escalating antimicrobial resistance (AMR) crisis is inadequately captured by existing surveillance systems, particularly those of lower income settings. AMR surveillance systems typically collate data from routine culture and susceptibility testing performed in diagnostic bacteriology laboratories to support healthcare. Limited access to high quality culture and susceptibility testing results in the dearth of A…

  • Global burden of bacterial antimicrobial resistance in 2019

    Open Access•Christopher J L Murray, Kevin S Ikuta et al.•ARTICLE•The Lancet•2022

    BACKGROUND: Antimicrobial resistance (AMR) poses a major threat to human health around the world. Previous publications have estimated the effect of AMR on incidence, deaths, hospital length of stay, and health-care costs for specific pathogen-drug combinations in select locations. To our knowledge, this study presents the most comprehensive estimates of AMR burden to date. METHODS: We estimated deaths and disability-adjusted life-years (DALYs) a…

  • Excess mortality attributable to antimicrobial-resistant bacterial bloodstream infection at a tertiary-care hospital in Indonesia

    Open Access•Patricia M Tauran, Irawaty Djaharuddin et al.•ARTICLE•PLOS Global Public Health•2022

    The burden of antimicrobial-resistant (AMR) infections in low and middle-income countries (LMICs) is largely unknown. Here, we evaluate attributable mortality of AMR infections in Indonesia. We used routine databases of the microbiology laboratory and hospital admission at Dr. Wahidin Sudirohusodo Hospital, a tertiary-care hospital in South Sulawesi from 2015 to 2018. Of 77,752 hospitalized patients, 8,341 (10.7%) had at least one blood culture t…

  • Use of antimicrobials during the Covid-19 pandemic

    Open Access•Binod Dhungel, Upendra Thapa Shrestha et al.•ARTICLE•PLOS Global Public Health•2023

    The COVID-19 pandemic was a major public health threat and the pressure to find curative therapies was tremendous. Particularly in the early critical phase of the pandemic, a lot of empirical treatments, including antimicrobials, were recommended. Drawing on interviews with patients, clinicians and drug dispensers, this article explores the use of antimicrobials for the management of COVID-19 in Nepal. A total of 30 stakeholders (10 clinicians, 1…

  • Association between Charlson Comorbidity Index and positive blood cultures at a tertiary-care hospital in Indonesia

    Open Access•Patricia M Tauran, Mansyur Arif et al.•ARTICLE•PLOS Global Public Health•2025

    Blood culture (BC) tests are a scarce resource in low- and middle-income countries (LMICs); therefore, prioritization based on likelihood of positive results might be beneficial. We aimed to determine whether comorbidities in the Charlson Comorbidity Index (CCI) were associated with positive BC tests among patients with suspected hospital-acquired bacteremia. We analysed a retrospective cohort from health records at Dr. Wahidin Sudirohusodo Hospi…

Antibiotic Use and Resistance (5 obras) · Medicine (5 obras) · Antibiotic Resistance in Bacteria (3 obras) · Antibiotics (3 obras) · Bacterial Identification and Susceptibility Testing (3 obras) · Biology (3 obras) · Disease (3 obras) · Internal Medicine (3 obras) · Antibiotic resistance (2 obras) · Confounding (2 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae